(Date:5/16/2008)...isease sufferers gain benefit from calcitriol, an ...News) -- Taking activated vitamin D may cut the ri...onic kidney disease by about one quarter, a new st...e than 1,400 patients, those being treated with ca... their overall risk of death lowered by 26 percent...
(Date:5/16/2008)...iser Seeks to Raise $38 Million for Life-threateni...ewswire/ -- Walkers in nearly,every state will rai...7 and,18 -- by participating in GREAT STRIDES, the...sis Foundation announced today., May is National ...s a,life-threatening genetic disease that causes f...
(Date:5/16/2008)...mine who would benefit most from chemo after surge...hDay News) -- A panel of 15 genes may help determi...lung cancer will experience a recurrence and, ther...tudy shows. , By extension, the same genetic s...essive forms of the cancer who would be able to fo...
(Date:5/16/2008)...ds Focus on Millions of Children Still in Danger, ...r UNICEF and The,Advertising Council today announc...s of national public service announcements (PSAs) ...r, Nicole Ritchie, Joel Madden, David,Duchovny, Te...vors of the,Myanmar cyclone. The Ad Council is dis...
Breaking Medicine News(10 mins):Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3(Date:5/16/2008)...rates Statistically Significant Reductions in Sele... - Abstract to be published in 2008 Proceedings of... Clinical Oncology, SAN DIEGO, May 16 /PRNewswire...x: ANX ) announced today that, in a registrationa...ted a statistically significant reduction,in gener...
(Date:5/15/2008)... N.J., May 15 /- Eisai Corporation of...6 clinical data abstracts about,compounds in the c...preclinical oncology research have been accepted f...American Society of Clinical Oncology (ASCO),taki... A wide variety of abstracts on Eisai marketed pro...
(Date:5/15/2008)...May 15 /- Medivation, Inc.,... ongoing Phase 1-2 clinical,trial of its novel and...ted,in an oral presentation at the 44th American S...in Chicago., Session title: New Targeted Strate...te and time: Monday, June 2 at 11:30 a.m. Central ...
(Date:5/15/2008)...acy Clinical Data from Prostate, Colorectal and Ov...Company to Hold Investor Event on Sun., June 1 wit..., May 15 /- Poniard,Pharmac...al company focused,on oncology, today announced th...al trials of picoplatin, in various tumor types an...
Breaking Medicine Technology:ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Precyse Solutions Appoints Karen Heisler as New Corporate Vice President Human Resources 16952 1Precyse Solutions Appoints Karen Heisler as New Corporate Vice President Human Resources 16952 221 Days to Creating Your Dream Life Will be Unleashed on April 28 2008 16949 121 Days to Creating Your Dream Life Will be Unleashed on April 28 2008 16949 2Anavex appoints Dr Dimitri Goundis to lead Clinical Development 4641 1Anavex appoints Dr Dimitri Goundis to lead Clinical Development 4641 2Anavex appoints Dr Dimitri Goundis to lead Clinical Development 4641 3Anavex appoints Dr Dimitri Goundis to lead Clinical Development 4641 4Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 1823 1Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 1823 2... WASHINGTON, DC, June 11, 2007 /PRNewswire-FirstC... and Medicine at Georgetown,University Medical Cen...es of Neurochem Inc.,s North American Phase III cl...present today an update on,Neurochem,s investigati...mer,s disease (AD). The presentation by Dr. Aisen ...
... ~ Valopicitabine achieved both primary and second...raction was observed between,valopicitabine and ri...wire-FirstCall/ -- Idenix,Pharmaceuticals, Inc. to...ed to evaluate triple combination therapy, consist...candidate for the,treatment of hepatitis C, pegyla...
Other Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6...ected curve trial lenses are ground with the same ...nd are invaluable in treating low vision patients....rs contain a disproportionately large number of le... to produce, and fewer lenses in the higher power ...
simplified focusing guidance system has made the LM-770 the easiest instrument to use of its type. Technicians can be trained to operate the LM-770 with a minimum of instruction. The instrument tells
...on electronic refractor to its line of Vision Diag...ce of a wireless, infrared remote control and is p...s. The Evolution gives the practitioner complete c...eld remote control. With the Evolution, the practi...
Marco Radiusgauges are available with either a standard or digital display as well as in either monocular or binocular form. All offer the functions of two instruments in one, measuring both the curv
Medicine Products: